Unleash the potential of genomic medicine using AI
We optimize the use of biological data-guided rational design and AI to predict the best molecular constructs in pre-clinical genomic medicine.
ALFRED AI
Our Proprietary AI-Led Framework for Rational Exploration in Drug design
Combining advanced algorithms, curated databases, and cutting-edge computational biology, we optimize therapeutic candidates for safety and efficacy across diverse modalities such as AAV, lentivirus, and nanoparticles.
Applications
That Target Product Profile Moment
Our AI-driven approach empowers collaborators to achieve breakthrough solutions in genomic medicine, saving time and resources while delivering precise, effective cell & gene modalities across therapeutic areas.
Gene & RNA-based therapies
Target Receptors Identification & Viral Vector Design
- Tech R&D
- In Silico Design
- Wet Lab Validation
- CNSCNS: 77%
- OphthalmologyOphthalmology: 56%
- Rare diseaseRare disease: 56%
- OncologyOncology: 56%
Non Viral Vector Design
- Tech R&D
- In Silico Design
- Wet Lab Validation
- OncologyOncology: 77%
Payload design
- Tech R&D
- In Silico Design
- Wet Lab Validation
- OncologyOncology: 56%
About Us
Mission & Team
WhiteLab Genomics stands at the convergence of AI and biology. Founded in 2019, backed by Y-Combinator, we’re pioneering the accelerated development of life-saving genomic medicines. By leveraging our proprietary technology, we use AI and advanced computational methods to analyze complex biological data to significantly accelerate and de-risk drug development.
Careers
Join the WhiteLab Team!
Be part of a team where care is at our heart, collective potential is embraced, and proactive communication, respect, and a can-do attitude form the foundation of our achievements. Together, we strive to make groundbreaking advancements in medicine and transform the future of healthcare.